Cmed Technology Invited to Participate at World TB Day
Cmed Technology, an eClinical technology provider, announced today it has been invited to participate at the annual World TB Day, which is being held tomorrow at Washington, D.C.’s U.S. Capitol Visitor Center. Throughout the day, Cmed Technology will conduct live demonstrations of its latest on-demand eClinical platform, Timaeus 5, using an Apple iPad®.
Tomorrow’s Senate briefing discusses the current state of tuberculosis (TB) and drug-resistant TB strains. Tuberculosis is a global problem; one of 10 people infected will develop the active form of the disease during their lifetime, according to the World Health Organization (WHO). The Bacille Calmette Guerin (BCG) vaccine, which is currently the only available vaccine against tuberculosis, provides limited protection against pulmonary tuberculosis and is not effective in adults. There is currently no licensed vaccine in the United States.
Cmed Technology’s Timaeus, which manages clinical data from Study Design through Reporting, has been supporting large-scale TB trials in difficult and remote geographies since 2008. In many countries, especially developing countries, trial sites may be situated in remote locations where Internet connectivity is unstable or not available at all. Because Timaeus allows clinicians to maintain full data communication using only mobile and/or low-speed connections without loss of performance, clinical trial sites can electronically capture data on-demand, allowing the data to be managed and reviewed in real time regardless of a site’s location.
“Cmed Technology Group feels honored to have been asked to participate at World TB Day because of our Timaeus eClinical platform being used to capture, manage and report clinical trial data in remote geographies with challenging circumstances,” said James Haughwout, Cmed Technology’s Vice President of Commercialization and Operations. “By giving trial sites the means to not being tethered to fixed, high-speed Internet connections, Cmed Technology is letting physicians bring innovation to wherever patients are located. Our hope is that Timaeus will help speed up the development of TB vaccines and treatments.”
What: World TB Day, demonstration of Timaeus 5 using an Apple iPad®
Where: U.S. Capitol Visitor Center, Rooms 210-212, Washington, D.C.
When
: March 24, 2011 (Thursday), 11 a.m.-2 p.m.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
